Testing a diabetes drug for gout prevention
Treatments studied
Part of Bones, joints & muscles, Genetic & congenital, Hormones & metabolism clinical trials.
This study tests if a type 2 diabetes medication (SGLT2 inhibitor) can help people with frequent gout flares. It aims to lower uric acid levels and reduce flare-ups.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have had at least 1 gout flare in the past year
- Your blood uric acid level is 6 mg/dL or higher
- You are between 18 and 80 years old
- You are willing to follow the study procedures
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an investigational tablet called BR2251 to see if it can lower uric acid levels in people with gout and hyperuricemia (too much uric acid in the blood). If you qualify, you may get a new treatment that could help prevent painful gout attacks.
This trial tests if empagliflozin, a medication typically used for diabetes, can help people with metabolic syndrome (a cluster of conditions like large waist size, high blood sugar, and high blood pressure). It may improve health and reduce the risk of heart disease.
This trial tests an experimental drug, SSS11, to see if it is safe and how it affects uric acid levels in people with gout and high uric acid. You may not take other gout medicines during the study.
This trial tests a medicine called empagliflozin (usually used for diabetes) to see if it can help people with very advanced kidney disease and diabetes. The study will check if this drug can slow down further kidney damage and improve overall kidney health.
This trial tests how combining a ketone supplement with certain diabetes medicines affects blood sugar and ketone levels. It may help adults with type 2 diabetes who are not on insulin or certain other drugs.
This trial tests if a diabetes medication (SGLT2i) can help prevent calcium kidney stones. Researchers want to see if it changes the way your urine absorbs and processes minerals.
Hear when a new Gout and Hyperuricemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.